BR0202748A - Pharmaceutical composition containing chitosan and aloe vera hydrochloride - Google Patents

Pharmaceutical composition containing chitosan and aloe vera hydrochloride

Info

Publication number
BR0202748A
BR0202748A BR0202748-8A BR0202748A BR0202748A BR 0202748 A BR0202748 A BR 0202748A BR 0202748 A BR0202748 A BR 0202748A BR 0202748 A BR0202748 A BR 0202748A
Authority
BR
Brazil
Prior art keywords
aloe vera
pharmaceutical composition
hydrochloride
chitosan
composition containing
Prior art date
Application number
BR0202748-8A
Other languages
Portuguese (pt)
Inventor
Mauro Cesar Marghet Laranjeira
Rozangela Curi Pedrosa
Valfredo Tadeu De Favere
Roberto Coury Pedrosa
Reginaldo Geremias
Original Assignee
Kito Ind E Com De Produtos Qui
Ind Farmaceutica Santa Terezin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kito Ind E Com De Produtos Qui, Ind Farmaceutica Santa Terezin filed Critical Kito Ind E Com De Produtos Qui
Priority to BR0202748-8A priority Critical patent/BR0202748A/en
Publication of BR0202748A publication Critical patent/BR0202748A/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA CONTENDO CLORIDRATO DE QUITOSANA E ALOE VERA". é composição farmacêutica de quitosana e Aloe vera para uso oral em humanos com vistas se obter alternativas terapêuticas para redução de colesterol, que contém cloridrato de quitosana de baixa massa molar e Aloe vera na proporção de quatro partes de cloridrato de quitosana para uma parte de Aloe vera e encapsulação de 256 mg de cloridrato de quitosana junto com 64 mg de extrato de Aloe vera, perfazendo 320 mg por cápsula."Pharmaceutical composition containing chitosan and aloe vera chloride". is a pharmaceutical composition of chitosan and aloe vera for oral use in humans with a view to obtaining cholesterol-lowering therapeutic alternatives, which contain low molecular weight chitosan hydrochloride and aloe vera in the ratio of four parts chitosan hydrochloride to one part aloe. vera and encapsulation of 256 mg chitosan hydrochloride together with 64 mg aloe vera extract to 320 mg per capsule.

BR0202748-8A 2002-07-12 2002-07-12 Pharmaceutical composition containing chitosan and aloe vera hydrochloride BR0202748A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BR0202748-8A BR0202748A (en) 2002-07-12 2002-07-12 Pharmaceutical composition containing chitosan and aloe vera hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BR0202748-8A BR0202748A (en) 2002-07-12 2002-07-12 Pharmaceutical composition containing chitosan and aloe vera hydrochloride

Publications (1)

Publication Number Publication Date
BR0202748A true BR0202748A (en) 2004-05-11

Family

ID=32181265

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0202748-8A BR0202748A (en) 2002-07-12 2002-07-12 Pharmaceutical composition containing chitosan and aloe vera hydrochloride

Country Status (1)

Country Link
BR (1) BR0202748A (en)

Similar Documents

Publication Publication Date Title
BRPI0309544B8 (en) storage stable oral pharmaceutical preparation comprising oxycodone and naloxone
BRPI0113539B8 (en) process for preparing pharmaceutical compositions for use with soft gelatin formulations
NO20034863L (en) Deuterated 3-piperidinopropiophenone as well as drugs containing these compounds
BRPI0518266A2 (en) modified-release oral medicinal product of at least one active ingredient in multi-capsule form
BR9908587A (en) Dust Inhaler
BR0015580A (en) Analgesic compositions containing buprenorphine
BR0012869A (en) Multi-component Pharmaceutical Dosage Form
BR9813827A (en) Opioid analgesic applicable in mammals and method to prevent the abusive oral use of an oral opioid formulation
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
BR9911890A (en) Preparation containing high molecular weight medicinal product in powder form for administration through the mucosa
WO2000078294A3 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
GEP20063882B (en) Dosage regimen and pharmaceutical composition for emergency contraception
EE04997B1 (en) Pharmaceutical composition containing loteprednol and antihistamines, a medicament containing these agents, a process for the preparation of the medicament and use of a combination of these agents
TR200101633T2 (en) Pharmaceutical composition
BR0114100A (en) Controlled release formulations for oral administration
BR0214497A (en) Pharmaceutical composition comprising a 5ht1 receptor agonist
BR0111868A (en) Pharmaceutical Compositions
PT1425005E (en) PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS LUMIRACOXIB
AR015744A1 (en) USE OF DEXMEDETOMIDINE FOR SEDATION IN INTENSIVE THERAPY
BRPI0408295A (en) use of a compound
BR0112847A (en) Use of a solid dosage form
BR0308038A (en) Ambroxol for the treatment of painful states in the oral cavity and pharynx
AR065139A1 (en) MEDICATION FOR THE TREATMENT OF ENDOMETRIOSIS
BRPI0412430A (en) zot and zonulin receptor agonist polypeptide
BR0206819A (en) Use of il-18 inhibitors for treatment and / or prevention of heart disease.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE 8A. ANUIDADE(S).

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.